【ADVENTA 7191 交流专区】稳大

Clip2

vincychong 发表于 1-10-2013 08:33 PM
明日就进场收票

很看好这股？ 可分享吗？

vincychong

Clip2 发表于 1-10-2013 01:35 PM
很看好这股？ 可分享吗？

因敏源 技术分析教父看好这PN 17 股。
我跟风而已!很看好就没有啦。
PARKING75至85仙关口，等着投机！
分享？不解决PN17明年1 月初就将离开马股噢！
很多公司解决PN17问题后，就啦！
是冷门股较容易HANDLE.
15 跟 16 它的命运是哪个？

Clip2

vincychong 发表于 1-10-2013 11:14 PM
因敏源 技术分析教父看好这PN 17 股。
我跟风而已!很看好就没有啦。
PARKING75至85仙关口，等着投机！{ ...

之前在这股赚了很多？买在低价？卖在块多？ 你也是投机的？ 我之前买sersol,有赚到一点，前天贪心在进，以为会起回。哪里知道赚的都吐回出来还倒贴。。。唉。。。 现在要看好好才进。。。 有点怕了。。。

vincychong

Clip2 发表于 1-10-2013 04:33 PM
之前在这股赚了很多？买在低价？卖在块多？ 你也是投机的？ 我之前买sersol,有赚到一点，前天贪心在进，以 ...

我多數是投資的啦！投機是我樂趣，看看有幾好運吧了！
不是這股。是別只股。
賺大錢好像Uzma.這裡朋友講我是玩冷門股！？
冷門股比較好好玩，那些玩冷門股性格很容易懂。
至少我還能懂他們在想什麼事物！

icy97

稳大独家销售Crawford

财经新闻 财经  2013-10-06 09:09
（吉隆坡5日讯）稳大（ADVENTA，7191，主板工业产品股）向马交所报备，与Crawford保健私人有限公司签署长期独家销售合约。

根据文告，稳大独资子公司———Sun保健（马）私人有限公司，昨天与Crawford保健签署上述合约，Sun保健获得Crawford保健疗伤产品在大马和东协国家的独家销售权。

稳大在文告指出，这项合约将有助扩大该公司在区域的分销网络。[南洋网财经]

ADVENTA BERHAD

Type	Announcement
Subject	OTHERS
Description	Adventa Berhad ("Adventa" or "the Company") - Distribution Agreement between Sun Healthcare (M) Sdn. Bhd. and Crawford Healtcare Ltd
The Board of Directors of Adventa wishes to announce that its wholly-owned subsidiary, Sun Healthcare (M) Sdn. Bhd. ("Sun Healthcare") had signed a long term exclusive Distribution Agreement with Crawford Healthcare Ltd. ("Crawford"), a leading advanced medical device company in the UK. Sun Healthcare will take over the exclusive sales and marketing of all Crawford’s woundcare products in Malaysia and the Asean countries, leveraging on its network of distribution in the region. This announcement is dated 4 October 2013.

icy97

ADVENTA BERHAD

Type	Announcement
Subject	OTHERS
Description	Adventa Berhad ("Adventa" or "the Company") - Additional Information on the Distribution Agreement  between Sun Healthcare (M) Sdn. Bhd. and Crawford Healtcare Ltd
Further the Company's announcement on 4 October 2013 ("Previous Annoucement"), the Board of Directors of Adventa wishes to append herewith the following additional information:- 1)        Crawford Healthcare Limited ("Crawford") is a wholly-owned subsidiary of Crawford Healthcare Holdings Limited,  a company incorporated in England and Wales.  Its principal activities are engaged in the supply and distribution of dermatology and woundcare products covering a broad range of skin conditions. 2)        The long term exclusive Distribution Agreement referred to in the Previous Announcement covers an initial term of five (5) years, thereafter subject to review for renewal. 3)        The exclusive distributorship of Crawford’s woundcare products in Malaysia and the Asean countries by Sun Healthcare (M) Sdn. Bhd. include a range of wound care solutions designed to manage and absorb exudate, manage wound infections, debride and deslough wounds, and aid wound healing.   These products includes KerraMax Care , KerraMax Care Boader, KerraLite Cool, KerraPro, KeraFibre, KerraFoam, Kerraped Planter Ulcer, KerraPed and ExSalt range. This announcement is dated 7 October 2013.

vincychong

咯！

929

如果它可以脫離pn17,股價將會再上，我想可以脫穎而出的機會大點

vincychong

929 发表于 6-12-2013 02:47 AM
如果它可以脫離pn17,股價將會再上，我想可以脫穎而出的機會大點

稳大正准备

Kevlee

vincychong 发表于 6-12-2013 11:47 AM
稳大正准备

好！！！！我就握着票，等待它飞翔！！！！！！！

vincychong

我們剩下時間少得可憐。不用重組可以嗎 ？
一定要可以

icy97

稳大末季净利暴跌89%

财经新闻 财经  2013-12-24 10:06
（吉隆坡23日讯）稳大（ADVENTA，7191，主板工业产品股）2013财年末季净利暴跌88.72%，但全年净利飙涨多达2.2倍。

稳大末季净利按年滑落88.72，从上财年1152万9000令吉，降低至130万令吉。

相比于上财年的480万5000令吉，稳大末季营业额按年上扬18%，至现财年的566万9000令吉。

稳大全年净利报8242万3000令吉，高于2012财年的2554万2000令吉，涨幅高达222.7%。

营业额则涨升93%，从上财年1419万3000令吉，扬升至2737万6000令吉。

稳大表示，全年盈利和销售表现报捷，主要是旗下业务的收入增加，供应消毒服务的业务进一步扩充，而医疗供应业务更有出口往区域市场支撑盈利增长。[南洋网财经]

SUMMARY OF KEY FINANCIAL INFORMATION 31/10/2013

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/10/2013	31/10/2012	31/10/2013	31/10/2012
		$$'000	$$'000	$$'000	$$'000

1	Revenue	5,669	4,805	27,376	14,193
2	Profit/(loss) before tax	1,404	3,079	83,034	2,180
3	Profit/(loss) for the period	1,300	11,571	82,418	25,496
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,300	11,529	82,423	25,542
5	Basic earnings/(loss) per share (Subunit)	0.85	7.55	53.95	16.72
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.4800		1.5600

Kevlee

重组计划不懂如何！？？？？几时到期哦？？？？

icy97

ADVENTA BERHAD

Type	Announcement
Subject	PRACTICE NOTE 17 / GUIDANCE NOTE 3 MONTHLY ANNOUNCEMENT
Description	ADVENTA BERHAD ("ADVENTA" OR "THE COMPANY") - MONTHLY UPDATE ON THE STATUS OF THE COMPANY'S REGULARISATION PLAN PURSUANT TO THE PRACTICE NOTE 17 OF THE MAIN MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD ("PN17")
Reference is made to the announcement made on 2 December 2013 and 31 December 2013, the Board of Directors of Adventa is pleased to announce that Adventa had on 31 December 2013 submitted an application to Bursa Malaysia Securtities Berhad to uplift Adventa from classification of “Affected Listed Issuer” under Practice Note 17 of the Main Market Listing Requirements (“Listing Requirements”) and a waiver from complying with Paragraph 8.04(3)(a) of the Listing Requirements. This announcement is dated 2 January 2014.

Kevlee

icy97 发表于 3-1-2014 03:11 AM

只是呈交而已，还没批准。但是有谁有内幕？？？？？

vincychong

版主这是什么意思的豁免？
waiver from complying with Paragraph 8.04(3)(a) of the Listing Requirements.

vincychong

Paragraph 8.04(3)(a) 是什么条件？

williamnkk81

vincychong 发表于 4-1-2014 12:16 AM
Paragraph 8.04(3)(a) 是什么条件？

2.0 Criteria for PN 17

2.1 Pursuant to paragraphs 8.04(2) of the Listing Requirements, where a listed issuer triggers any one or more of the following Prescribed Criteria it must comply with the provisions of paragraph 8.04 and this Practice Note:      

(a) the shareholders’ equity of the listed issuer on a consolidated basis is 25% or less of the issued and paid-up capital (excluding treasury shares) of the listed issuer and such shareholders’ equity is less than RM40 million;

(b) receivers or managers have been appointed over the asset of the listed issuer, its subsidiary or associated company which asset accounts for at least 50% of the total assets employed of the listed issuer on a consolidated basis;

(c) a winding up of a listed issuer’s subsidiary or associated company which accounts for at least 50% of the total assets employed of the listed issuer on a consolidated basis;

(d) the auditors have expressed an adverse or disclaimer opinion in the listed issuer’s latest audited financial statements;

(e) the auditors have expressed a modified opinion with emphasis on the listed issuer’s going concern in the listed issuer’s latest audited financial statements and the shareholders’ equity of the listed issuer on a consolidated basis is 50% or less of the issued and paid-up capital (excluding treasury shares) of the listed issuer;

(f) a default in payment by a listed issuer, its major subsidiary or major associated company, as the case may be, as announced by a listed issuer pursuant to Practice Note 1 and the listed issuer is unable to provide a solvency declaration to the Exchange;

   

(g) the listed issuer has suspended or ceased:-

           (i) all of its business or its major business; or

           (ii) its entire or major operations,

     for any reasons whatsoever including, amongst others, due to or as a result of:-

           (aa) the cancellation, loss or non-renewal of a licence, concession or such other

                      rights necessary to conduct its business activities;

           (bb) the disposal of the listed issuer's business or major business; or

           (cc) a court order or judgment obtained against the listed issuer prohibiting the

                      listed issuer from conducting its major operations on grounds of infringement

                      of copyright of products etc; or
(h) the listed issuer has an insignificant business or operations.

3.0 Regularisation Plan

3.1 Pursuant to paragraph 8.04(3) of the Listing Requirements, a PN17 Company must regularise its condition by undertaking a regularisation plan. In this regard, a PN17 Company and its Principal Adviser must ensure that the regularisation plan -

(a) is sufficiently comprehensive and capable of resolving all problems, financial or otherwise that had caused the PN17 Company to trigger the Prescribed Criteria;

(b) enables the PN17 Company to regularise its financial condition and level of operations, such that the PN17 Company no longer triggers any of the Prescribed Criteria; and

(c) is fair and reasonable to the PN17 Company and its shareholders and will increase shareholder value.

4.0 Disclosure obligations of the PN17 Company

4.1 Pursuant to paragraph 8.04(3)(b) of the Listing Requirements, a PN17 Company must announce to the Exchange -

(a) on an immediate basis ( "First Announcement") upon the PN17 Company triggering one or more of the Prescribed Criteria -
(i) that the listed issuer is a PN17 Company pursuant to this Practice Note;
(ii) the listed issuer’s obligations pursuant to this Practice Note;
(iii) the consequences of non-compliance with such obligations; and
(iv) the status of the listed issuer’s regularisation plan or the status of its endeavours to formulate such a plan, whichever is applicable, or where neither a plan nor any endeavour to formulate such a plan has been undertaken, an appropriate negative statement to such effect;

(b) within 3 months from the First Announcement, on whether the regularisation plan will result in a significant change in the business direction or policy of the PN17 Company;

(c) the status of its regularisation plan and the number of months to the end of the relevant timeframes referred to in paragraph 5.1 or 5.2 below, as may be applicable, on a monthly basis ("Monthly Announcement") until further notice from the Exchange;

(d) its compliance or non-compliance with a particular obligation imposed pursuant to this Practice Note, on an immediate basis;

(e) details of the regularisation plan which announcement must fulfill the requirements set out in paragraph 4.2 below ("Requisite Announcement"); and

(f) where the PN 17 Company fails to regularise its condition, the dates of suspension and de-listing of its listed securities, immediately upon notification of suspension and de-listing by the Exchange.

4.2 The Requisite Announcement must -

(a) contain details of the regularisation plan and sufficient information to demonstrate that the PN17 Company is able to comply with all the requirements set out under paragraph 3.1 above after implementation of the regularisation plan;
(b) include a timeline for the complete implementation of the regularisation plan; and
(c) be announced by the PN17 Company’s Principal Adviser.

4.3 Before a PN17 Company makes the Requisite Announcement, it must ensure that -
(a) all agreements to be entered into with third parties as part of the regularisation plan, have been duly executed by all parties to such agreements; and
(b) where the regularisation plan involves a compromise or arrangement with the PN17 Company’s creditors, the PN17 Company has taken reasonable steps to procure the agreement-in-principle of such creditors.

4.4 The Monthly Announcements must be made on the first market day of each month beginning with the month following the date of the First Announcement.

5.0 Obligation to Regularise

5.1 If a PN17 Company undertakes a regularisation plan which will result in a significant change in the business direction or policy of the PN17 Company, it must –
(a) submit the plan to the SC for approval, within 12 months from the date of the First Announcement; and
(b) complete the implementation of the plan within such timeframe as may be prescribed by the SC.

5.2 If a PN17 Company undertakes a regularisation plan which will not result in a significant change in the business direction or policy of the PN17 Company, it must –
(a) submit to the Exchange the plan and obtain the Exchange’s approval to implement the plan within 12 months from the date of the First Announcement;
(b) complete the implementation of the plan within 6 months from the date the plan is approved by the Exchange. However, for cases which involve court proceedings, a PN17 Company has up to 12 months from the date the plan is approved by the Exchange, to complete the implementation of the plan; and
(c) record a net profit in 2 consecutive quarterly results immediately after the completion of the implementation of the plan. In this regard, the PN17 Company must ensure that the relevant quarterly results are subjected to a limited review by an external auditor before they are announced to the Exchange.

vincychong

1月7號能不能知道，穩大保得著上市地位嗎？
如果有內幕消息可以從股價看到！？
Pemandu的計劃算被介受嗎？

ricolwc

什么意思噢。。。。出牌？？

Type	Announcement
Subject	PRACTICE NOTE 17 / GUIDANCE NOTE 3 OTHERS
Description	ADVENTA BERHAD (“ADVENTA” OR “COMPANY”) PRACTICE NOTE 17/ GUIDANCE NOTE 3
We refer to the Company’s announcement dated 31 December 2013 in respect of the Company’s application to Bursa Malaysia Securities Berhad (“Bursa Securities”) to uplift Adventa from the classification of “Affected Listed Issuer” under Practice Note 17 of the Main Market Listing Requirements of Bursa Securities (“Listing Requirements”) and a waiver from complying with Paragraph 8.04(3)(a) of the Listing Requirements (“Application”). On behalf of the Board of Directors of Adventa, AmInvestment Bank Berhad wishes to announce that Bursa Securities has, vide its letter dated 6 January 2014, informed the Company that the suspension on the trading of the Company's securities and de-listing of the Company in accordance with Paragraph 8.04(5) of the Listing Requirements shall be deferred pending Bursa Securities' decision on the Application. Thus, Adventa’s shares shall remain listed and tradable on the Main Market of Bursa Securities pending the decision from Bursa Securities. This announcement is dated 6 January 2014.